{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:59:40Z","timestamp":1767992380389,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11154-018-9477-9","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T02:33:08Z","timestamp":1543804388000},"page":"349-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Myo-inositol in autoimmune thyroiditis, and hypothyroidism"],"prefix":"10.1007","volume":"19","author":[{"given":"Poupak","family":"Fallahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Martina","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusy","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ragusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina Rosaria","family":"Paparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"9477_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/0-387-27600-9_1","volume":"39","author":"PP Murthy","year":"2006","unstructured":"Murthy PP. Structure and nomenclature of inositol phosphates, phosphoinositides, and glycosylphosphatidylinositols. Subcell Biochem. 2006;39:1\u201319.","journal-title":"Subcell Biochem"},{"key":"9477_CR2","first-page":"881","volume":"13","author":"T Hartig","year":"1855","unstructured":"Hartig T. Ueber das Klebermehl. Bot Zeitung. 1855;13:881.","journal-title":"Bot Zeitung"},{"key":"9477_CR3","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/ajcn\/33.9.1954","volume":"33","author":"RS Clements Jr","year":"1980","unstructured":"Clements RS Jr, Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr. 1980;33:1954\u201367.","journal-title":"Am J Clin Nutr"},{"key":"9477_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0009-8981(97)00161-7","volume":"266","author":"NM Hooper","year":"1997","unstructured":"Hooper NM. Glycosyl-phosphatidylinositol anchored membrane enzymes. Clin Chim Acta. 1997;266:3\u201312.","journal-title":"Clin Chim Acta"},{"key":"9477_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature05185","volume":"443","author":"G Paolo Di","year":"2006","unstructured":"Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651\u20137.","journal-title":"Nature"},{"key":"9477_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/bj2200345","volume":"220","author":"MJ Berridge","year":"1984","unstructured":"Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J. 1984;220:345\u201360.","journal-title":"Biochem J"},{"key":"9477_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/bst0170259","volume":"17","author":"CP Downes","year":"1989","unstructured":"Downes CP. Twenty-fifth Colworth medal lecture. The cellular functions of myo-inositol. Biochem Soc Trans. 1989;17:259\u201368.","journal-title":"Biochem Soc Trans"},{"key":"9477_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1432-1033.1990.tb19297.x","volume":"193","author":"CP Downes","year":"1990","unstructured":"Downes CP, Macphee CH. Myo-inositol metabolites as cellular signals. Eur J Biochem. 1990;193:1\u201318.","journal-title":"Eur J Biochem"},{"key":"9477_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/bj2470519","volume":"247","author":"JB Field","year":"1987","unstructured":"Field JB, Ealey PA, Marshall NJ, Cockcroft S. Thyroid-stimulating hormone stimulates increases in inositol phosphates as well as cyclic AMP in the FRTL-5 rat thyroid cell line. Biochem J. 1987;247:519\u201324.","journal-title":"Biochem J"},{"key":"9477_CR10","first-page":"152","volume":"79","author":"B Corvilain","year":"1994","unstructured":"Corvilain B, Laurent E, Lecomte M, Vansande J, Dumont JE. Role of the cyclic adenosine 3\u2032,5\u2032-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab. 1994;79:152\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"9477_CR11","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1210\/jc.2007-0660","volume":"92","author":"Y Song","year":"2007","unstructured":"Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, et al. Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab. 2007;92:3764\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"9477_CR12","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1210\/jc.2007-0366","volume":"92","author":"H Grasberger","year":"2007","unstructured":"Grasberger H, Van Sande J, Hag-Dahood Mahameed A, Tenenbaum-Rakover Y, Refetoff S. A familial thyrotropin (TSH) receptormutation provides in vivo evidence that the inositol phosphates\/Ca2+ cascade mediates TSH action on thyroid hormone synthesis. J Clin Endocrinol Metab. 2007;92:2816\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"9477_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-065X.2008.00750.x","volume":"228","author":"DA Fruman","year":"2009","unstructured":"Fruman DA, Bismuth G. Fine tuning the immune response with PI3K. Immunol Rev. 2009;228:253\u201372.","journal-title":"Immunol Rev"},{"key":"9477_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12026-007-0075-2","volume":"39","author":"M Kashiwada","year":"2007","unstructured":"Kashiwada M, Lu P, Rothman PB. PIP3 pathway in regulatory T cells and autoimmunity. Immunol Res. 2007;39:194\u2013224.","journal-title":"Immunol Res"},{"key":"9477_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2013.08.042","volume":"133","author":"JF S\u00e9\u00eft\u00e9","year":"2014","unstructured":"S\u00e9\u00eft\u00e9 JF, Goutsmedt C, Youinou P, Pers JO, Hillion S. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells. J Allergy Clin Immunol. 2014;133:181\u20138.e1\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"9477_CR16","first-page":"48","volume-title":"Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text","author":"P Kopp","year":"2013","unstructured":"Kopp P. Thyroid hormone synthesis. In: Braverman LE, Cooper DS, editors. Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Wolters Kluwer Lippincott Williams & Wilkins; 2013. p. 48\u201374.","edition":"10"},{"key":"9477_CR17","doi-asserted-by":"publisher","first-page":"e74856","DOI":"10.1371\/journal.pone.0074856","volume":"8","author":"M Oliveira de","year":"2013","unstructured":"de Oliveira M, Luvizotto Rde A, Olimpio RM, De Sibio MT, Conde SJ, Biz Rodrigues Silva C, et al. Triiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activation. PLoS One. 2013;8:e74856.","journal-title":"PLoS One"},{"key":"9477_CR18","first-page":"183","volume-title":"Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text","author":"SW Spaulding","year":"2005","unstructured":"Spaulding SW. Biological actions of thyrotropin. In: Braverman LE, Utiger RD, editors. Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 183\u201397.","edition":"9"},{"key":"9477_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fimmu.2013.00047","volume":"4","author":"M Gumbleton","year":"2013","unstructured":"Gumbleton M, Kerr WG. Role of inositol phospholipid signaling in natural killer cell biology. Front Immunol. 2013;4:47.","journal-title":"Front Immunol"},{"key":"9477_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2013.00288","volume":"4","author":"N Srivastava","year":"2013","unstructured":"Srivastava N, Sudan R, Kerr WG. Role of inositol poly-phosphatases and their targets in T cell biology. Front Immunol. 2013;4:288.","journal-title":"Front Immunol"},{"key":"9477_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jbior.2012.08.001","volume":"53","author":"V Pouillon","year":"2013","unstructured":"Pouillon V, Mar\u00e9chal Y, Frippiat C, Erneux C, Schurmans S. Inositol 1,4,5-trisphosphate 3-kinase B (Itpkb) controls survival, proliferation and cytokine production in mouse peripheral T cells. Adv Biol Regul. 2013;53:39\u201350.","journal-title":"Adv Biol Regul"},{"key":"9477_CR22","unstructured":"Belilos E, Carsons S. Antiphospholipid syndrome. http:\/\/emedicine.medscape.com\/article\/ 333221-overview . Accessed Sept 2018."},{"key":"9477_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1398-9995.1998.tb04951.x","volume":"53","author":"S Romagnani","year":"1998","unstructured":"Romagnani S. The Th1\/Th2 paradigm and allergic disorders. Allergy. 1998;53:12\u20135.","journal-title":"Allergy"},{"key":"9477_CR24","doi-asserted-by":"publisher","first-page":"e611","DOI":"10.1016\/j.lpm.2012.10.002","volume":"41","author":"J Orgiazzi","year":"2012","unstructured":"Orgiazzi J. Thyroid autoimmunity. Presse Med. 2012;41:e611\u201325.","journal-title":"Presse Med"},{"key":"9477_CR25","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","volume":"25","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Fallahi P, Ferrari SM, Pupilli C, d'Annunzio G, Lorini R, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med. 2008;25:1349\u201353.","journal-title":"Diabet Med"},{"key":"9477_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/EJE-06-0591","volume":"156","author":"A Antonelli","year":"2007","unstructured":"Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M, et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol. 2007;156:431\u20137.","journal-title":"Eur J Endocrinol"},{"key":"9477_CR27","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.metabol.2008.04.023","volume":"57","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Carpi A, et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism. 2008;57:1270\u20137.","journal-title":"Metabolism"},{"key":"9477_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","volume":"13","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13:272\u201380.","journal-title":"Autoimmun Rev"},{"key":"9477_CR29","unstructured":"Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol. 2009;27:22\u20137."},{"key":"9477_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cyto.2011.04.022","volume":"55","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, et al. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine. 2011;55:288\u201393.","journal-title":"Cytokine"},{"key":"9477_CR31","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1210\/endo.136.11.7588238","volume":"136","author":"AW Kung","year":"1995","unstructured":"Kung AW, Lau KS, Wong NS. Interferon-gamma increases intracellular calcium and inositol phosphates in primary human thyroid cell culture. Endocrinology. 1995;136:5028\u201333.","journal-title":"Endocrinology"},{"key":"9477_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1677\/jme.0.0200293","volume":"20","author":"AW Kung","year":"1998","unstructured":"Kung AW, Lau KS. Gamma-interferon activates a nuclear protein that binds to the gamma-interferon activation site of the thyroglobulin gene. J Mol Endocrinol. 1998;20:293\u20138.","journal-title":"J Mol Endocrinol"},{"key":"9477_CR33","doi-asserted-by":"publisher","first-page":"424163","DOI":"10.1155\/2013\/424163","volume":"2013","author":"M Nordio","year":"2013","unstructured":"Nordio M, Pajalich R. Combined tretament with Myo-inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. J Thyroid Res. 2013;2013:424163.","journal-title":"J Thyroid Res"},{"key":"9477_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/09513590.2013.829445","volume":"29","author":"G Morgante","year":"2013","unstructured":"Morgante G, Musacchio MC, Orvieto R, Massaro MG, De Leo V. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes. Gynecol Endocrinol. 2013;29:967\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"Suppl 2","key":"9477_CR35","first-page":"51","volume":"21","author":"M Nordio","year":"2017","unstructured":"Nordio M, Basciani S. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto\u2019s patients with subclinical hypothyroidism. Eur Rev Med Pharmacol Sci. 2017;21(Suppl 2):51\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 2","key":"9477_CR36","first-page":"36","volume":"21","author":"SM Ferrari","year":"2017","unstructured":"Ferrari SM, Fallahi P, Di Bari F, Vita R, Benvenga S, Antonelli A. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis. Eur Rev Med Pharmacol Sci. 2017;21(Suppl 2):36\u201342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9477_CR37","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1258\/ebm.2009.009241","volume":"235","author":"H Ohye","year":"2010","unstructured":"Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood). 2010;235:424\u201333.","journal-title":"Exp Biol Med (Maywood)"},{"key":"9477_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14:174\u201380.","journal-title":"Autoimmun Rev"},{"key":"9477_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.autrev.2016.09.009","volume":"15","author":"P Fallahi","year":"2016","unstructured":"Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R, et al. The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev. 2016;15:1125\u20138.","journal-title":"Autoimmun Rev"},{"key":"9477_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/08916930802170401","volume":"41","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Fallahi P, Delle Sedie A, Ferrari SM, Maccheroni M, Bombardieri S, et al. High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. Autoimmunity. 2008;41:537\u201342.","journal-title":"Autoimmunity"},{"key":"9477_CR41","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.imbio.2012.08.267","volume":"218","author":"A Antonelli","year":"2013","unstructured":"Antonelli A, Ferrari SM, Mancusi C, Mazzi V, Pupilli C, Centanni M, et al. Interferon-\u03b1, \u2212\u03b2 and -\u03b3 induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor \u03b3 agonists. Immunobiology. 2013;218:690\u20135.","journal-title":"Immunobiology"},{"key":"9477_CR42","doi-asserted-by":"publisher","first-page":"E413","DOI":"10.1210\/jc.2010-0923","volume":"95","author":"A Antonelli","year":"2010","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, et al. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves\u2019 and normal thyrocyte. J Clin Endocrinol Metab. 2010;95:E413\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"9477_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cyto.2008.01.002","volume":"42","author":"A Antonelli","year":"2008","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Sebastiani M, et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine. 2008;42:137\u201343.","journal-title":"Cytokine"},{"key":"9477_CR44","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1677\/ERC-08-0337","volume":"16","author":"A Antonelli","year":"2009","unstructured":"Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, et al. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists. Endocr Relat Cancer. 2009;16:1299\u2013311.","journal-title":"Endocr Relat Cancer"},{"key":"9477_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","volume":"25","author":"A Antonelli","year":"2014","unstructured":"Antonelli A, Ferrari SM, Corrado A, Ferrannini E, Fallahi P. CXCR3, CXCL10 and type 1 diabetes. Cytokine Growth Factor Rev. 2014;25:57\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9477_CR46","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1210\/jc.2010-2905","volume":"96","author":"A Antonelli","year":"2011","unstructured":"Antonelli A, Ferrari SM, Frascerra S, Di Domenicantonio A, Nicolini A, Ferrari P, et al. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab. 2011;96:1859\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"9477_CR47","doi-asserted-by":"publisher","first-page":"468107","DOI":"10.1155\/2012\/468107","volume":"2012","author":"P Fallahi","year":"2012","unstructured":"Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli A. Cytokines and HCV-related disorders. Clin Dev Immunol. 2012;2012:468107.","journal-title":"Clin Dev Immunol"},{"issue":"Suppl 2","key":"9477_CR48","first-page":"89","volume":"21","author":"S Benvenga","year":"2017","unstructured":"Benvenga S, Vicchio T, Di Bari F, Vita R, Fallahi P, Ferrari SM, et al. Favorable effects of myo-inositol, selenomethionine or their combination on the hydrogen peroxide-induced oxidative stress of peripheral mononuclear cells from patients with Hashimoto's thyroiditis: preliminary in vitro studies. Eur Rev Med Pharmacol Sci. 2017;21(Suppl 2):89\u2013101.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9477_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.yexcr.2010.12.007","volume":"317","author":"R Alon","year":"2011","unstructured":"Alon R, Shulman Z. Chemokine triggered integrin activation and actin remodeling events guiding lymphocyte migration across vascular barriers. Exp Cell Res. 2011;317:632\u201341.","journal-title":"Exp Cell Res"},{"key":"9477_CR50","doi-asserted-by":"publisher","first-page":"a018788","DOI":"10.1101\/cshperspect.a018788","volume":"7","author":"D Cantrell","year":"2015","unstructured":"Cantrell D. Signaling in lymphocyte activation. Cold Spring Harb Perspect Biol. 2015;7:a018788.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9477_CR51","first-page":"2153","volume":"22","author":"M Nordio","year":"2018","unstructured":"Nordio M, Basciani S. Evaluation of thyroid nodule characteristics in subclinical hypothyroid patients under a myo-inositol plus selenium treatment. Eur Rev Med Pharmacol Sci. 2018;22:2153\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-018-9477-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T23:11:32Z","timestamp":1720825892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-018-9477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1007\/s11154-018-9477-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"3 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}}]}}